drugset / Trial / NCT03183739

Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects

NCT03183739

Phase 1 Completed 36 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to evaluate the safety and tolerability and evaluate pharmacokinetics of single and multiple ascending oral doses of ASP8062 in nonelderly Japanese male and female subjects.

Timeline

Start
2017-06-20
Primary completion
2017-10-06
Completion
2017-10-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP8062 Unknown Oral

Indications

No indication recorded.